Acquired thrombocytopenia
MONDO:0001198An instance of thrombocytopenia that is acquired during the lifetime of the individual.
Also known as: acquired thrombocytopenia, secondary thrombocytopenia
25 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New drug could help liver disease patients avoid bleeding during surgery
Disease control OngoingThis study tests a drug called herombopag in people with chronic liver disease who have low platelet counts and need surgery. The goal is to see if the drug can safely raise platelet levels enough to reduce bleeding risk during the procedure. About 101 adults with mild to moderat…
Phase: PHASE3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Real-world study examines caplacizumab for aTTP: better treatment on the horizon?
Disease control OngoingThis study looks back at how doctors in Germany prescribed caplacizumab (Cablivi) for acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood clotting disorder. Researchers will analyze data from 350 patients to see how well the drug works outside of clinical trials and…
Sponsor: University of Cologne • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New rapid test could speed up diagnosis of deadly blood clotting disorder
Diagnosis OngoingThis study is testing a new, faster blood test for diagnosing acquired thrombotic thrombocytopenic purpura (aTTP), a rare but life-threatening blood clotting disorder. The new test, called HemosIL AcuStar, will be compared to two existing tests in 500 patients from Spain and Port…
Sponsor: Fundación Española de Hematología y Hemoterapía • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC